Alternative and straightforward synthesis of dopaminergic 5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine

Synthetic Communications

Volumn 41, Issue 13, 2011, Pages 2017-2024

  Öztaşkin, Necla ^a   Göksu, Süleyman ^a   Hasan Secen ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Aminotetralin; Birch reduction; Curtius rearrangement; Dopamine; neurotransmitter; Synthesis

Indexed keywords

2 NAPHTHOIC ACID; 5 METHOXY 1,2,3,4 TETRAHYDRONAPHTHALEN 2 AMINE; DOPAMINE DERIVATIVE; HYDROCHLORIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIRCH REDUCTION; BROMINATION; CURTIUS REARRANGEMENT; DOPAMINERGIC ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESTERIFICATION; HYDROGENOLYSIS;

EID: 79955692724     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397911.2010.495043     Document Type: Article

References (33)

1. 3 receptor antagonist. CNS Drug Rev. 1998, 4, 42-53. (Pubitemid 28449763)
2. Cannon, J. G. Dopamine agonists: Structure-activity relationships. Prog. Drug Res. 1985, 29, 303-414. (Pubitemid 16165831)
3. (a) Woodruff, G. N. Dopamine receptors: A review. Comp. Gen. Pharmacol. 1971, 2, 439-455;
4. (b) Abel, M. S.; Clement-Cormier, Y. Dopmine receptor characterization agonist requirements for binding using [H-3]-6,7-dihydroxy-1,2,3,4- tetrahydronapthalene (ADTN) potential specific dopamine receptor ligand. Pharmacologist 1978, 20, 241.
5. (a) McDermed, J. D.; McKenzie, G. M.; Phillips, A. P. Synthesis and pharmacology of some 2-aminotetralins: Dopamine receptor agonists. J. Med. Chem. 1975, 18, 362-367;
6. (b) Cannon, J. G.; Lee, T.; Goldman, H. D.; Costall, B.; Naylor, R. J. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration. J. Med. Chem. 1977, 20, 1111-1116. (Pubitemid 8170466)
7. (a) Gancher, S. T.; Woodward, W. R.; Boucher, B.; Nutt, J. G. Peripheral pharmacokinetics of apomorphine in humans. Ann. Neurol. 1989, 26, 232-238; (Pubitemid 19193092)
8. (b) Papatsoris, A. G.; Deliveliotis, C.; Singer, C.; Papapetropoulos, S. Erectile dysfunction in Parkinson's disease. Urology 2006, 67, 447-451. (Pubitemid 43343516)
9. McDermed, J. D.; McKenzie, G. M.; Freeman, H. S. Synthesis and dopaminergic activity of (+=-)-, (+)-, and (-)-2-dipropylamino-5-hydroxy-1,2,3, 4-tetrahydronaphthalene. J. Med. Chem. 1976, 19, 547-549.
10. Hacksell, U.; Svensson, U.; Nilsson, J. L. G.; Hjorth, S.; Carlsson, A.; Wikström, H.; Lindberg, P.; Sanchez, D. N-Alkylated 2-aminotetralins: Central dopamine-receptor stimulating activity. J. Med. Chem. 1979, 22, 1469-1475. (Pubitemid 10190292)
11. 4 receptors of 2-aminotetralins: Relevance of D2 agonist binding for determination of receptor subtype selectivity. J. Med. Chem. 1996, 39, 4233-4237. (Pubitemid 26339833)
12. 2A receptor. Bioorg. Med. Chem. Lett. 1999, 9, 2167-2172. (Pubitemid 29371928)
13. 1-agonist activity of 2-aminotetralins. J. Med. Chem. 1982, 25, 136-141. (Pubitemid 12106632)
14. Martin, Y. C.; Jarboe, C. H.; Krause, R. A.; Lynn, K. R.; Dunnigan, D.; Holland, J. B. Potential anti-Parkinson drugs designed by receptor mapping. J. Med. Chem. 1973, 16, 147-150.
15. (a) Hacksell, U.; Arvidsson, L. E.; Johansson, A. M.; Nilsson, J. L. G.; Sanchez, D.; Lindberg, P.; Wikström, H.; Svensson, K.; Hjorth, S.; Carlsson, A.; Ask, A. L.; Öǧren, S. O. Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives. Acta Pharm. Suec. 1986, 23, 77-90; (Pubitemid 16025858)
16. (b) Holmberg, P.; Sohn, D.; Leideborg, R.; Caldirola, P.; Zlatoidsky, P.; Hanson, S.; Mohell, N.; Rosqvist, S.; Nordvall, G.; Johansson, A. M.; Johansson, R. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists. J. Med. Chem. 2004, 47, 3927-3930; (Pubitemid 38970953)
17. (c) Homan, E. J.; Copinga, S.; Unelius, L.; Jackson, D. M.; Wikström, H. V.; Grol, C. J. Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT. Bioorg. Med. Chem. 1999, 7, 1263-1271. (Pubitemid 29292368)
18. (a) Yao, B.; Ji, H. T.; Cao, Y. B.; Zhou, Y. J.; Zhu, J.; Lü, J. G.; Li, Y. W.; Chen, J.; Zheng, C. H.; Jiang, Y. Y.; Liang, R. M.; Tang, H. Synthesis and antifungal activities of novel 2-aminotetralin derivatives. J. Med. Chem. 2007, 50, 5293-5300; (Pubitemid 350057841)
19. (b) Yao, B.; Zhou, Y. J.; Zhu, J.; Lü, J. G.; Li, Y. W.; Cheng, J.; Jiang, Q. F.; Zheng, C. H. Design, synthesis, and biological evaluation of non-azole inhibitors of lanosterol 14 alpha-demethylase of fungi. Chin. Chem. Lett. 2006, 17, 1189-1192. (Pubitemid 44758462)
20. Ye, Q. Z.; Grunewald, G. L. Conformationally defined adrenergic agents, 15: Conformationally restricted and conformationally defined tyramine analogs as inhibitors of phenylethanolamine N-methyltransferase. J. Med. Chem. 1989, 32, 478-486. (Pubitemid 19061894)
21. (a) Ames, D. E.; Evans, D.; Grey, T. F.; Islip, P. J.; Richards, K. E. The synthesis of alkoxy-1,2,3,4-tetrahydronaphthalene derivatives, I: 2-Amino-, alkylamino-, and dialkylamino derivatives. J. Chem. Soc. 1965, 2636-2641;
22. (b) Hacksell, U.; Arvidsson, L. E.; Svensson, U.; Nilsson, J. L. G.; Wikström, H.; Lindberg, P.; Sanchez, D.; Hjorth, S.; Carlsson, A.; Paalzow, L. Monophenolic 2-(dipropylamino)indans and related compounds: Central dopamine-receptor stimulating activity. J. Med. Chem. 1981, 24, 429-434; (Pubitemid 11151648)
23. (c) Copinga, S.; Tepper, P. G.; Grol, C. J.; Horn, A. S.; Dubocovich, M. L. 2-Amido-8-methoxytetralins: A series of nonindolic melatonin-like agents. J. Med. Chem. 1993, 36, 2891-2898; (Pubitemid 23315392)
24. (d) Hirayama, Y.; Ikunaka, M.; Matsumoto, J. An expeditious scalable synthesis of (S)-2-amino-5-methoxytetralin via resolution. Org. Process. Res. Develop. 2005, 9, 30-38. (Pubitemid 40249104)
25. (a) Göksu, S.; Kazaz, C.; Sütbeyaz, Y.; Seçen, H. A concise synthesis of 2-amino-1,2,3,4- tetrahydronaphthalene-6,7-diol ('6,7-ADTN') from naphthalene-2,3-diol. Helv. Chim. Acta 2003, 86, 3310-3313; (Pubitemid 37392275)
26. (b) Göksu, S.; Seçen, H.; Sütbeyaz, Y. An alternative synthesis of the dopaminergic drug 2-amino-1,2,3,4-tetrahydronaphthalene-5,6- diol (5,6-ADTN). Helv. Chim. Acta 2006, 89, 270-273; (Pubitemid 43332249)
27. (c) Göksu, S.; Seçen, H. Concise syntheses of 2-aminoindans via indan-2-ol. Tetrahedron 2005, 61, 6801-6807. (Pubitemid 40813427)
28. Gopalsamy, A.; Lim, K.; Ellingboe, J. W.; Mitsner, B.; Nikitenko, A.; Upeslacis, J.; Mansour, T. S.; Olson, M. W.; Bebernitz, G. A.; Grinberg, D.; Feld, B.; Moy, F. J.; O'Connell, J. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors. J. Med. Chem. 2004, 47, 1893-1899. (Pubitemid 38453909)
29. Göksu, S.; Uǧuz, M. T.; Özdemir, H.; Seçen, H. A concise synthesis and the antibacterial activity of 5,6-dimethoxynaphthalene-2- carboxylic acid. Turk. J. Chem. 2005, 29, 199-205. (Pubitemid 40663599)
30. Ellingboe, J. W.; Lombardo, L. J.; Alessi, T. R.; Nguyen, T. T.; Guzzo, F.; Guinosso, C. J.; Bullinton, J.; Browne, E. N. C.; Bagli, J. F.; Wrenn, J.; Steiner, K.; McCaleb, M. L. Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides. J. Med. Chem. 1993, 36, 2485-2493. (Pubitemid 23270798)
31. Charlton, J. L.; Koh, K.; Plourde, G. L. An asymmetric synthesis of 2-amino-6,7- dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). Can. J. Chem. 1990, 68, 2028-2032.
32. Adcock, W.; Wells, P. R. Substituent effects in naphthalene, I: Syntheses of 4, 5, 6, 7, and 8-substituted 2-naphthoic acids. Aust. J. Chem. 1965, 18, 1351-1364.
33. Johnson, D. W.; Mander, L. N. Intramolecular alkylation, VI: The ortho-alkylation in phenolic diazoketones: Preparation of intermediates containing the 2,4-cyclohexadienone moiety suitable for gibberellin synthesis. Aus. J. Chem. 1974, 27, 1277-1286.